Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001421505 | SCV001624029 | likely benign | Neuronal ceroid lipofuscinosis 7 | 2023-12-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000868738 | SCV001847490 | likely benign | not provided | 2021-03-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002345993 | SCV002652772 | likely benign | Inborn genetic diseases | 2019-04-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001273686 | SCV001457016 | uncertain significance | Late-infantile neuronal ceroid lipofuscinosis | 2020-03-17 | no assertion criteria provided | clinical testing |